NPPA Fixes Retail Prices For 42 Formulations

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices for 42 pharmaceutical formulations. These prices are exclusive of Goods and Services Tax, if applicable. These prices were notified on February 7, 2025.

ICMR & CDSCO Seek Input On HMPV Real-Time PCR Evaluation Protocol

The current draft focuses specifically on laboratory performance evaluation of HMPV real-time PCR kits, with all clinical samples tested according to the candidate test’s instructions for use. The primary purpose is to evaluate the performance characteristics of these kits in diagnosing HMPV infection/disease.

Improvements in India’s Public Health

India’s National Health Mission (NHM) has made substantial strides in improving public health outcomes over the past three years, focusing on expanding healthcare human resources, addressing critical health challenges, and strengthening the healthcare system’s response to emergencies like the COVID-19 pandemic.

Draft Guidelines For The Pharmaceutical Industry In India

The Central Pollution Control Board (CPCB) has issued draft guidelines for the pharmaceutical industry aiming to regulate and mitigate its environmental impact. Stakeholders and the general public have until February 5, 2025, to provide their feedback on the proposed guidelines. Suggestions can be submitted via email to designated CPCB officials or sent to the IPC-I Division of CPCB in Delhi.

Guidance Document Validation Of Rapid Diagnostics For Pathogen Identification And Antimicrobial Susceptibility Testing, 2025

The Indian Council of Medical Research (ICMR) has released a comprehensive guidance document for the validation of rapid diagnostics aimed at pathogen identification and antimicrobial susceptibility testing (AST). This document bridges existing gaps in the validation process and provides a framework for innovators and developers to ensure their diagnostic tools meet regulatory standards.

CDSCO Sub-Zonal Office in Uttarakhand Relocates to Dehradun

The Central Drugs Standard Control Organization (CDSCO) has announced the relocation of its Sub-Zonal Office in Uttarakhand. All official submissions and communications should now be directed to its new address at CDSCO, Sub-Zonal Office The Survey of India, Survey Chowk Campus Plot No. 68, 17 EC Road Dehradun-248001 Uttarakhand.